ML Slovak

602 citations

17 papers · 493 indexed · h-index 11

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Genetics top 10%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 10
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 4
Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Co-authors: Susan P.C. Cole Clive Evans S E Mirski Jeffrey M. Trent Kurt C. Almquist RS Negrin Elisabeth G.E. de Vries PM Parker
Journals: Blood (4 papers)Journal of Clinical Oncology (2 papers)British Journal of Cancer (2 papers)Leukemia (2 papers)Lung Cancer (1 paper)
Partner nations: United States Austria Denmark

In The Last Decade

ML Slovak

16 papers receiving 490 citations

Peers

Countries citing papers authored by ML Slovak

Since Specialization

Citations

This map shows the geographic impact of ML Slovak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ML Slovak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ML Slovak more than expected).

Fields of papers citing papers by ML Slovak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ML Slovak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ML Slovak. The network helps show where ML Slovak may publish in the future.

Co-authorship network

The 25 scholars most cited alongside ML Slovak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with ML Slovak Line = papers co-authored together ML Slovak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	The idic(X)(q13) in myeloid malignancies: breakpoint clustering in segmental duplications and association with TET2 mutations Human Molecular Genetics ·Kajsa Paulsson, Claudia Haferlach, Christa Fonatsch, A. Hagemeijer, Mie Andersen, ML Slovak, B. Johansson	2010	24
2	Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16). Blood ·Margaret O’Donnell, PM Parker, Andrew Dagis, ML Slovak, D. Snyder, Anthony S. Stein, Ricardo Spielberger, Anna Pawłowska, Joseph Rosenthal, Joycelynne Palmer, Neil Kogut, Stephen J. Forman	2008	0
3	Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients Leukemia ·E. M. Kalugina, MR O’Donnell, ML Slovak, M. Spickard, Y. Masuoka, I. A. Hutton, SJ Forman	2002	22
4	Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission Leukemia ·DS Snyder, А.В. Буташин, MR O’Donnell, PM Parker, AS Stein, Kim Margolin, George Somlo, A Molina, Ricardo Spielberger, A. Kashyap, Henry C. Fung, ML Slovak, Andrew Dagis, RS Negrin, Ayu Chrismonica Islami, KG Blume, SJ Forman	1999	81
5	197 t(3;5) High-grade myelodysplasia and acute myeloid leukemia of young adults responds favorably to allogeneic bone marrow transplantation Leukemia Research ·Daniel A. Arber, Kai-Hsin Chang, Ricardo Spielberger, ML Slovak	1997	1
6	Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia. Journal of Clinical Oncology ·Margaret O’Donnell, G D Long, Pablo Parker, Joyce C. Niland, AP Nademanee, M Amylon, Nelson J. Chao, RS Negrin, G. Schmidt, ML Slovak	1995	51
7	Rearrangement of chromosome band 11q13 in HeLa cells. PubMed ·Rachel A. Jesudasan, ML Slovak, Subrata Sen, Eri S. Srivatsan	1995	8
8	The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. PubMed ·ML Slovak, Amanda L King, Susan P.C. Cole, Yang Zhen-hon, 胡业荣, Elisabeth G.E. de Vries, HJ Broxterman, G L Scheffer, RJ Scheper	1995	82
9	Altered topoisomerase IIα in a drug-resistant small cell lung cancer cell line selected in VP-16 Lung Cancer ·S E Mirski, Clive Evans, Kurt C. Almquist, ML Slovak, Susan P.C. Cole	1994	54
10	Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection British Journal of Cancer ·Jennifer E. Dingman, Xin‐Yuan Guan, ML Slovak, Satheeshkumar Palaniappan, SL O'Rourke	1994	7
11	Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non- Hodgkin's lymphoma Blood ·l Emine, ML Slovak, А.В. Буташин, RK Brynes, I. A. Hutton, SJ Forman	1994	6
12	Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome Blood ·L Nagarajan, Jiří Zavadil, David F. Claxton, Xinyan Lu, Jeff Fairman, P. Lukin, J.J. Wasmuth, Xu Cheng, Alireza Sadeghian, ML Slovak	1994	39
13	Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome Blood ·L Nagarajan, Jiří Zavadil, David F. Claxton, Xinyan Lu, Jeff Fairman, P. Lukin, J.J. Wasmuth, Xu Cheng, Alireza Sadeghian, ML Slovak	1994	26
14	Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. Journal of Clinical Oncology ·N J Chao, H.-P. Feuerpeil, GD Long, GM Schmidt, Timothy A. Donlon, PM Parker, ML Slovak, Fernández M Mónica L., KG Blume, Stephen J. Forman	1991	47
15	Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms. PubMed ·ML Slovak, Marco Coccia, Paul S. Meltzer, Jeffrey M. Trent	1991	12
16	Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression British Journal of Cancer ·David R. Shalinsky, ML Slovak, S B Howell	1991	9
17	Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations. PubMed ·ML Slovak, Gerald A. Hoeltge, Jeffrey M. Trent	1987	24

About ML Slovak

ML Slovak is a scholar working on Hematology, Genetics, Biotechnology, Pharmacology and Pathology and Forensic Medicine, having authored 17 papers that have together received 493 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (2 papers) and DNA and Nucleic Acid Chemistry (2 papers). The work is most often cited by research in Hematology (258 citations), Genetics (85 citations), Oncology (169 citations), Public Health, Environmental and Occupational Health (138 citations) and Molecular Biology (197 citations). ML Slovak has collaborated with scholars based in United States, Austria and Denmark. Frequent co-authors include Susan P.C. Cole, Clive Evans, S E Mirski, Jeffrey M. Trent, Kurt C. Almquist, RS Negrin, Elisabeth G.E. de Vries, PM Parker, RJ Scheper and G L Scheffer. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Cancer, Leukemia and Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact